Recall Z-0829-2018— Fresenius Medical Care Renal Therapies Group, LLC

Class II · Terminated

Class II FDA medical device recall by Fresenius Medical Care Renal Therapies Group, LLC, initiated 2017-10-05, terminated 2021-07-28. It names 5 FDA 510(k) clearances: K121341, K120505, K120017 and 2 more. Product: 2008T, Hemodialysis Delivery System Product Indicated for acute and chronic dialysis therapy.. Reason: While reviewing documentation for the next software release of the 2008T, an R&D technician identified that setting the UF goal to '0' introduces a discrepancy between the UF rate displayed and the actual UF pump rate. The software anomaly is also applicable to the 2008T Machines that contained the 2.63 Bug Fix per DCAF 17-088. 2008T Upgrade kits that contained the 2.63 Bug Fix are also affected. Additionally, SW version 2.64 (in design freeze) is also impacted by this anomaly..

Recalling firm
Fresenius Medical Care Renal Therapies Group, LLC
Classification
Class II
Status
Terminated
Initiated
2017-10-05
Terminated
2021-07-28
Firm location
Waltham, MA, United States

510(k) clearances named in this recall

5 on FDA's record

K-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.

Product description

2008T, Hemodialysis Delivery System Product Indicated for acute and chronic dialysis therapy.

Reason for recall

While reviewing documentation for the next software release of the 2008T, an R&D technician identified that setting the UF goal to '0' introduces a discrepancy between the UF rate displayed and the actual UF pump rate. The software anomaly is also applicable to the 2008T Machines that contained the 2.63 Bug Fix per DCAF 17-088. 2008T Upgrade kits that contained the 2.63 Bug Fix are also affected. Additionally, SW version 2.64 (in design freeze) is also impacted by this anomaly.

Data sourced from openFDA. This site is unofficial and independent of the FDA.